SCLERODERMA, SYSTEMIC
Clinical trials for SCLERODERMA, SYSTEMIC explained in plain language.
Never miss a new study
Get alerted when new SCLERODERMA, SYSTEMIC trials appear
Sign up with your email to follow new studies for SCLERODERMA, SYSTEMIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to halt progression of Hard-to-Treat 'Hard Skin' disease
Disease control CompletedThis study tested whether a new oral medication called BI 685509 could help control progressive systemic sclerosis, also known as scleroderma. Over 200 adults with active disease took either the drug or a placebo pill three times daily for at least 11 months. Researchers measured…
Matched conditions: SCLERODERMA, SYSTEMIC
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Apr 02, 2026 00:25 UTC
-
Researchers examine why scleroderma affects hands differently
Knowledge-focused CompletedThis study aimed to understand how scleroderma affects hand movement by comparing the dominant hand to the other hand in 30 patients. Researchers measured joint flexibility, skin thickness, and pain levels to see if there were differences between hands. The goal was to gather bas…
Matched conditions: SCLERODERMA, SYSTEMIC
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC
-
Scientists probe immune cells to unlock Scleroderma's scarring secrets
Knowledge-focused CompletedThis study aimed to understand how a type of immune cell, called B lymphocytes, might contribute to the scarring (fibrosis) seen in systemic sclerosis (scleroderma). Researchers compared cells from 71 people, including patients and healthy volunteers, to see how patient B cells i…
Matched conditions: SCLERODERMA, SYSTEMIC
Phase: NA • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC